Accéder au contenu
Merck

A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton's Tyrosine Kinase.

SLAS discovery : advancing life sciences R & D (2019-11-12)
L L Ong, J D Vasta, L Monereau, G Locke, H Ribeiro, M A Pattoli, S Skala, J R Burke, S H Watterson, J A Tino, P L Meisenheimer, B Arey, J Lippy, L Zhang, M B Robers, A Tebben, C Chaudhry
RÉSUMÉ

Protein kinases are intensely studied mediators of cellular signaling. While traditional biochemical screens are capable of identifying compounds that modulate kinase activity, these assays are limited in their capability of predicting compound behavior in a cellular environment. Here, we aim to bridge target engagement and compound-cellular phenotypic behavior by utilizing a bioluminescence resonance energy transfer (BRET) assay to characterize target occupancy within living cells for Bruton's tyrosine kinase (BTK). Using a diverse chemical set of BTK inhibitors, we determine intracellular engagement affinity profiles and successfully correlate these measurements with BTK cellular functional readouts. In addition, we leveraged the kinetic capability of this technology to gain insight into in-cell target residence time and the duration of target engagement, and to explore a structural hypothesis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Albumine de sérum bovin solution, 30% in saline, protease free, aseptically filled
Sigma-Aldrich
BTK active human, recombinant, expressed in baculovirus infected Sf9 cells, ≥80% (SDS-PAGE)